Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway
机构:[1]Key Discipline of Integrated Chinese and Western Medicine, Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China广东省中医院[2]AMI Key laboratory of Chinese Medicine in Guangzhou, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China广东省中医院[3]Beogene Biotech (Guangzhou) CO., LTD, Guangzhou, China[4]Department of Biomedical Engineering, Jinan University, Guangzhou, China
Our previous works have shown that tanshinone IIA inhibited maladaptive extracellular matrix remodeling in cardiac fibroblasts implicating its potential role in treating of pathologic cardiac remodeling. However, the intrinsically poor solubility and bioavailability of tanshinone IIA hindered its clinical application. Here we develop monomethoxy-poly (ethylene glycol)-poly (lactic acid)-D-alpha-Tocopheryl polyethylene glycol 1000 succinate (mPEG-PLA-TPGS) nanoparticle incorporating tanshinone IIA (tanshinone IIA-NPs) and study its efficacy in post-infarction left ventricular (LV) remodeling. Male C57BL/6 mice underwent left coronary artery ligation followed by subsequent intravenously injected tanshinone IIA-NPs therapy for 5 consecutive days. Treatment with tanshinone IIA-NP improved cardiac function, limited infarct expansion, and prevented left ventricle dilation at 4weeks post-MI. Furthermore, cardiomyocytes inflammation, apoptosis and myocardial fibrosis were significantly attenuated in tanshinone IIA-NP treated mice. These effects also correlated with inhibition of IB protein phosphorylation and NF-kappa B activation, leading to suppression of proinflammatory cytokine expression. Together, these results demonstrate tanshinone IIA-NP attenuated adverse cardiac remodeling and dysfunction mediated through prevention of IB phosphorylation and NF-kappa B activation. Tanshinone IIA-NP is a novel approach to treat myocardial IR injury in patients with MI.
基金:
National Science Foundation
(81573708, 81703877, 81473471), National Basic Research Program of
China (973 Program, 2015CB554400), Science Foundation of Guangdong
Province (2015A030306049, 2015A030310437, 2014A030313402),
Guangdong special support program for high-level talents
(2015TQ01R588) and Medical Science and Technology Research
Foundation of Guangdong Province (A2016192), the Science and
Technology Program of Guangzhou (201601010270, 2017010160489,
201704030083), the Pearl River S&T Nova Program of Guangzhou
(201710010155, 201806010072), and the Science and Technology Project
of Guangdong province (2015A010101313, 2017A050506011,
2017A050501013, 2017B090911012).
第一作者机构:[1]Key Discipline of Integrated Chinese and Western Medicine, Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China[2]AMI Key laboratory of Chinese Medicine in Guangzhou, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Key Discipline of Integrated Chinese and Western Medicine, Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China[2]AMI Key laboratory of Chinese Medicine in Guangzhou, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China[4]Department of Biomedical Engineering, Jinan University, Guangzhou, China[*1]Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China[*2]Department of Biomedical Engineering, Jinan University, Guangzhou 510632, China.
推荐引用方式(GB/T 7714):
Mao Shuai,Wang Lei,Chen Peipei,et al.Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway[J].ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY.2018,46:S707-S716.doi:10.1080/21691401.2018.1508028.
APA:
Mao, Shuai,Wang, Lei,Chen, Peipei,Lan, Yong,Guo, Rui&Zhang, Minzhou.(2018).Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway.ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY,46,
MLA:
Mao, Shuai,et al."Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway".ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 46.(2018):S707-S716